The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
Open accessAbstract
Objective: To explore consultants' and general practitioners' perceptions of the factors that influence their decisions to introduce new drugs into their clinical practice. Design: Qualitative study using semistructured interviews. Monitoring of hospital and general practice prescribing data for eight new drugs. Setting: Teaching hospital and nearby general hospital plus general practices in Birmingham. Participants: 38 consultants and 56 general practitioners who regularly referred to the teaching hospital. Main outcome measures: Reasons for prescribing a new drug; sources of information used for new drugs; extent of contact between consultants and general practitioners; and amount of study drugs used in hospitals and by general practitioners. Results: Consultants usually prescribed new drugs only in their specialty, used few new drugs, and used scientific evidence to inform their decisions. General practitioners generally prescribed more new drugs and for a wider range of conditions, but their approach varied considerably both between general practitioners and between drugs for the same general practitioner. Drug company representatives were an important source of information for general practitioners. Prescribing data were consistent with statements made by respondents. Conclusions: The factors influencing the introduction of new drugs, particularly in primary care, are more multiple and complex than suggested by early theories of drug innovation. Early experience of using a new drug seems to strongly influence future use. What is already known on this topic: UK studies show that use of new drugs by general practitioners is influenced by consultants, the nature of the drug, and perceived risk What this study adds: Consultants generally introduced fewer drugs than general practitioners, usually within their specialty Decisions were said to be based mainly on the evidence from the scientific literature and meetings General practitioners prescribed more new drugs and the basis of decisions was more varied Doctors' interpretations of using a new drug were not consistent
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Qualitative research in health care: Analysing qualitative data
Pope, C. (2000) · BMJ · doi:10.1136/bmj.320.7227.114 · Cited by 8,131
Research works printed but not linked: 21
- Ferner, 1996, Newly licensed drugs., BMJ, 313, 1157, 10.1136/bmj.313.7066.1157 · doi:10.1136/bmj.313.7066.1157
- 10.1016/0277-9536(90)90042-Q · DOI
- Griffin, 1993, The economic implications of therapeutic conservatism., J R Coll Physicians Lond, 27, 121
- Williamson, 1975, How general practitioners assess risks in using new drugs., J R Coll Gen Pract, 25, 383
- 10.1177/014107688207500510 · doi:10.1177/014107688207500510
- 10.1177/014107688007301208 · doi:10.1177/014107688007301208
- 10.1177/014107688808100407 · doi:10.1177/014107688808100407
- Taylor, 1991, Changes in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice., Br J Gen Pract, 41, 244
- Bryman A Burgess RG eds.Analysing qualitative data. London: Routledge, 1994.
- 10.1093/fampra/18.3.333 · doi:10.1093/fampra/18.3.333
- Jones, 1999, A survey of the advertising of nine new drugs in the general practice literature., J Clin Pharm Ther, 24, 451, 10.1046/j.1365-2710.1999.00255.x · doi:10.1046/j.1365-2710.1999.00255.x
- Avorn, 1982, Scientific versus commercial sources of influence on the prescribing behaviour of physicians., Am J Med, 73, 4, 10.1016/0002-9343(82)90911-1 · DOI · Paper page
- Allery, 1997, Why general practitioners and consultants change their clinical practice: a critical incident study., BMJ, 314, 870, 10.1136/bmj.314.7084.870 · DOI · Paper page
- 10.1136/bmj.312.7036.949 · DOI · Paper page
- Tomlin, 1999, General practitioners' perceptions of effective healthcare., BMJ, 318, 1532, 10.1136/bmj.318.7197.1532 · DOI
- Barrie, 1997, Questioning behaviour in general practice: a pragmatic study., BMJ, 315, 1512, 10.1136/bmj.315.7121.1512 · DOI
- Berkwits, 1998, From practice to research: the case for criticism in an age of evidence., Soc Sci Med, 47, 1539, 10.1016/S0277-9536(98)00232-9 · DOI
- 10.1093/fampra/16.4.407 · DOI
- Walshe K Sheldon TA .Dealing with clinical risk: implications of the rise of evidence based health care. Public Money Manag 1998; Oct-Dec:15–20. · doi:10.1111/1467-9302.00136
- 10.1016/S0277-9536(98)00250-0 · DOI
- Jones, 2000, Prescribing new drugs: a survey of hospital consultants in the West Midlands., Int J Pharm Pract, 8, 285, 10.1111/j.2042-7174.2000.tb01017.x · doi:10.1111/j.2042-7174.2000.tb01017.x
Cited by
Timing of new black box warnings and withdrawals for prescription medications
Lasser, K. E. (2002) · JAMA · doi:10.1001/jama.287.17.2215 · Cited by 1,005
Influences on GPs' decision to prescribe new drugs--the importance of who says what
Prosser, H. (2003) · Family Practice · doi:10.1093/fampra/20.1.61 · Cited by 318
Theodorou, M., Tsiantou, V., Pavlakis, A., Maniadakis, N., Fragoulakis, V., Pavi, E., & Kyriopoulos, J. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-150 · Cited by 124
Managing the new wave of weight loss medication in general practice: A qualitative study
Andreassen, P., Jensen, S. D., Bruun, J. M., & Sandbæk, A. (2024) · Clinical Obesity · doi:10.1111/cob.12666 · Cited by 23
Metadata
- Authors
- Jones, M. I., Greenfield, S. M., & Bradley, C. P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2001-08-18
- Volume
- 323
- Issue
- 7309
- Pages
- 378.1
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1991598189
- Cited by
- 175
- References
- 1
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prescribing new drugs: qualitative study of influences on consultants and general practitioners. https://app.cochat.ai/papers/10.1136/bmj.323.7309.378
- The paper
- Jones, M. I., Greenfield, S. M., & Bradley, C. P. (2001). Prescribing new drugs: qualitative study of influences on consultants and general practitioners. BMJ. https://doi.org/10.1136/bmj.323.7309.378
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.